4th scientific Drug Delivery Conference

Virtual Conference on FORMULATION DEVELOPMENT and TECHNOLOGIES

Feb. 15th, 2022 | Live Streaming with live chatThis 1-day conference is an excellent opportunity for R&D Managers, Technology Experts and Business Development Managers who have specific interest in up-to-date formulation technologies and their special aspects in formulation and analytical development.

 

AgendaReview

What are the benefits of this Drug Delivery Conference?

International experts and guest speakers from industry and academia will be presenting relevant topics as well as the most current case studies.

The agenda will provide room for expert discussions and exchanging know-how. Participants will also be able to directly apply their learnings from this symposium to their daily work. For any questions, please contact ddcffm@losan.de

Losan Pharma company

AGENDA

DDC 2022 virtual conference

Tuesday, 15th of February 2022

9:00
Welcome & introduction

Dr. Jens Morgenthaler, General Manager Losan Pharma GmbH
Dr. François Boutignon, President & CEO APTYS Pharma

9:20
“Current developments in oral drug delivery systems”

Prof. Dr. Werner Weitschies
Institute of Pharmacy, University of Greifswald

10:00
„Nanoliposome (NLS) technology – a new innovative approach“

Dr. Ansgar Bögershausen and Dr. Matthias Rischer
Losan Pharma GmbH

11:00
„Formulations with phospholipids for the oral application”

Prof. Dr. Karsten Mäder
Institute of Pharmacy, University of Halle

11:40
„Non-conventional formulation development at Boehringer – Ingelheim“

Dr. Kerstin Schäfer
Boehringer-Ingelheim Pharma GmbH & Co. KG

01:30
„Printing technologies for individualized medicines“

Prof. Dr. Jörg Breitkreutz
Institute for Pharmaceutical Technology and Biopharmacy, University of Düsseldorf

02:10
„3D printing“

Dr. Simon Geissler
Merck Healthcare KGaA

03:10
„3D printing – the Losan approach“

Dr. Wolfgang Mohr / Dr. Philipp Schwarzer
Losan Pharma GmbH

03:50
„NanoSolution® case study: using nano milling to improve dissolution rate of abiraterone“

Dr. François Boutignon
President & CEO APTYS Pharma

04:30
Summary and farewell

Dr. Jens Morgenthaler, General Manager
Losan Pharma GmbH

Overview Losan DDC 2022

Date

February 15th, 2022
9:00 – 04:45

Participation fee

free

Virtual conference

Live Streaming with live chat

Symposium language

English

Chairman

Dr. François Boutignon, President & CEO APTYS Pharma

Co Chairman
Dr. Matthias Rischer, Losan Pharma GmbH

Registration

Registration is open from 10th January to 13th February

3rd Losan Drug Delivery Conference
Nanotechnology
hot melt extrusion
Drug development